Ophthalmic manifestations in patients with inflammatory bowel disease: A review.

Inflammatory bowel disease. N Engl J Med (2002) 21.17

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 13.50

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70

Crohn's disease. Lancet (2012) 4.42

Scleritis and episcleritis. Br J Ophthalmol (1976) 3.87

Ulcerative colitis. Lancet (2012) 3.38

[Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis]. Med Clin (Barc) (2005) 2.90

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol (2001) 2.33

Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol (2004) 2.25

Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol (2012) 2.24

Probable diffuse retinopathy caused by adalimumab in a patient with Crohn's disease. J Crohns Colitis (2012) 1.98

Scleral structure, organisation and disease. A review. Exp Eye Res (2004) 1.89

Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol (2005) 1.82

The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol (2000) 1.72

Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol (2010) 1.69

Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol (2003) 1.65

Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis (2004) 1.65

Optic perineuritis as the presenting feature of Crohn disease. J Neuroophthalmol (2012) 1.62

Inflammatory bowel disease and the eye. Surv Ophthalmol (2003) 1.62

Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol (1996) 1.53

Use of infliximab in the treatment of peripheral ulcerative keratitis in Crohn disease. Am J Ophthalmol (2011) 1.51

Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis. Ocul Immunol Inflamm (2003) 1.51

Patient awareness of extraintestinal manifestations of inflammatory bowel disease. J Crohns Colitis (2012) 1.45

A patient with ulcerative colitis and central serous chorioretinopathy--a therapeutic dilemma. J Crohns Colitis (2012) 1.40

Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2011) 1.39

The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol (2015) 1.34

Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol (2015) 1.34

Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci (1999) 1.34

Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis (2004) 1.22

Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis (2009) 1.22

Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology (2002) 1.21

The ocular manifestations of inflammatory bowel disease. Curr Opin Ophthalmol (2006) 1.18

The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis (2007) 1.14

Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Gastroenterology (2014) 1.12

Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev (2004) 1.08

Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology (2003) 1.07

Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr Gastroenterol Rep (2004) 1.07

Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol (2014) 1.04

Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn's disease. Int Ophthalmol (2001) 1.03

Ocular inflammation in Crohn's disease. Ophthalmology (1991) 1.03

Pyodermatitis-pyostomatitis vegetans of the eyelids case report and review of the literature. Ophthalmology (2005) 1.02

A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol (2007) 1.01

Lacrimal gland inflammation as the presenting sign of Crohn's disease. Can J Ophthalmol (2001) 1.00

Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep (2008) 0.98

Inflammatory bowel disease and smoking--a review. Am J Gastroenterol (1998) 0.97

Update on the use of systemic biologic agents in the treatment of noninfectious uveitis. Biologics (2014) 0.94

Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. J Rheumatol (2003) 0.94

Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations. MedGenMed (2007) 0.94

Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol (2014) 0.93

Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation. Clin Experiment Ophthalmol (2003) 0.93

Night blindness and Crohn's disease. Int Ophthalmol (2014) 0.92

Crohn's disease complicated by granulomatous interstitial nephritis, choroidal neovascularization, and central retinal vein occlusion. Intern Med (2008) 0.91

Infliximab and anterior optic neuropathy: case report and review of the literature. Graefes Arch Clin Exp Ophthalmol (2009) 0.89

Infliximab in chronic ocular inflammation. Int J Clin Pharmacol Ther (2005) 0.89

Etiologies of chronic anterior uveitis at a tertiary referral center over 35 years. Ocul Immunol Inflamm (2010) 0.88

Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion (2014) 0.88

New associations of classic acute macular neuroretinopathy. Br J Ophthalmol (2015) 0.87

Central retinal artery occlusion in Crohn disease. J AAPOS (2012) 0.86

Ocular complications of inflammatory bowel disease. ScientificWorldJournal (2015) 0.85

Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis (2002) 0.83

The genetic background of inflammatory bowel disease: from correlation to causality. J Pathol (2016) 0.83

Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants. J Crohns Colitis (2010) 0.82

Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease. Am J Gastroenterol (2003) 0.82

Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy. Dig Surg (2001) 0.82

Central retinal vein occlusion in two patients with inflammatory bowel disease. Retina (2000) 0.82

Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation. Am J Ophthalmol (2006) 0.82

Pharmacological therapy of vasculitis: an update. Curr Opin Pharmacol (2004) 0.82

Update in the management of extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep (2013) 0.82

The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med (2015) 0.82

Crohn's disease. Lancet (2016) 0.82

A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol (2016) 0.81

Uveitis in a patient receiving rifabutin for Crohn's disease. J R Soc Med (2004) 0.81

Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease. Scand J Rheumatol (2005) 0.81

Bilateral lid margin ulcers as the initial manifestation of Crohn disease. Am J Ophthalmol (2004) 0.81

[Retinal central vein occlusion in remission of Crohn's disease: case report]. Arq Bras Oftalmol (2008) 0.81

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis (2015) 0.81

Ocular Involvement in Systemic Autoimmune Diseases. Clin Rev Allergy Immunol (2015) 0.81

Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.81

Posterior reversible encephalopathy syndrome with PLEDs-plus due to mesalamine. J Neurosci Rural Pract (2014) 0.80

Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis. Int J Colorectal Dis (2006) 0.80

Inflammatory bowel disease emergencies. Gastroenterol Clin North Am (2003) 0.80

Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors. Surg Clin North Am (2015) 0.80

Ocular manifestations of inflammatory bowel disease. Curr Opin Ophthalmol (2016) 0.79

Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease. J Crohns Colitis (2015) 0.79

Bilateral phakic cystoid macular edema associated with Crohn's disease. South Med J (2002) 0.79

Orbital and optic nerve complications of inflammatory bowel disease. J Crohns Colitis (2012) 0.79

Ulcerative colitis. Lancet (2016) 0.79

Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits. J Crohns Colitis (2015) 0.78

Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease. Am J Ophthalmol (2012) 0.78

Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran. Arch Iran Med (2016) 0.77

Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature. BMC Gastroenterol (2013) 0.77

Consensus guidelines for the management of inflammatory bowel disease. Arq Gastroenterol (2010) 0.77

Pattern dystrophy of the retinal pigment epithelium in Crohn's disease. A case report. Ophthalmologica (2000) 0.76

Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Indian J Gastroenterol (2015) 0.76

Nonischemic central retinal vein occlusion in an adolescent patient with ulcerative colitis. Case Rep Ophthalmol Med (2012) 0.76

Ocular myasthenia gravis and inflammatory bowel disease: a case report and literature review. Br J Ophthalmol (2003) 0.76

Multifocal posterior uveitis in Crohn's disease. Graefes Arch Clin Exp Ophthalmol (2006) 0.76

Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease. Am J Ophthalmol (2002) 0.76

Advancements in the management of uveitis. Best Pract Res Clin Rheumatol (2016) 0.76

[Palpebral ptosis, a rare ocular manifestation of Crohn's disease]. Arch Soc Esp Oftalmol (2012) 0.76